Due to the potential role of SIRT5 as a pharmacological target in cancer, diabetes, cardiovascular diseases, obesity, neurodegenerative disorders, and inflammation, many studies have been undertaken to identify new molecules acting as SIRT5 activators or inhibitors. The gene discussed is SIRT5; the disease is obesity due to melanocortin 4 receptor deficiency.